SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001773427-22-000033
Filing Date
2022-08-04
Accepted
2022-08-04 06:38:59
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20220630.htm   iXBRL 10-Q 1478152
2 EX-31.1 swtx-20220630xex311.htm EX-31.1 11485
3 EX-31.2 swtx-20220630xex312.htm EX-31.2 11504
4 EX-32.1 swtx-20220630xex321.htm EX-32.1 5666
5 EX-32.2 swtx-20220630xex322.htm EX-32.2 5672
  Complete submission text file 0001773427-22-000033.txt   4738165

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20220630.xsd EX-101.SCH 24307
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT swtx-20220630_cal.xml EX-101.CAL 49655
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT swtx-20220630_def.xml EX-101.DEF 97744
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20220630_lab.xml EX-101.LAB 359142
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20220630_pre.xml EX-101.PRE 213000
45 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20220630_htm.xml XML 652263
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 221134518
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences